Naturade's Chairman and CEO Announce New Strategy
PARAMOUNT, Calif., July 14 /PRNewswire/ -- Naturade, Inc.'s (OTC Bulletin Board: NRDC) newly appointed Chairman, Ronald Ahrens, and Chief Executive Officer, Bill Stewart, will introduce Naturade's new business strategy at the National Nutritional Foods Association Trade Show, in San Antonio, Texas on July 15. Messrs. Ahrens and Stewart will present the three core components of Naturade's new strategy: i) introduce and aggressively merchandise Naturade's new, innovative Chinese herbal medicines into the U.S. market, ii) aggressively move to a consumer focus with differentiated products led by the company's superior protein powders, and skin care lotions, and iii) aggressively market and grow Naturade's new line extensions of its novel children's nutritional products.
Mr. Ahrens is the immediate past CEO of Merck Consumer Healthcare, Inc., and was responsible for supervising the Johnson & Johnson Merck joint venture which successfully introduced Pepcid AC(TM), the leading OTC switch product acid blocker. Prior to joining Merck, Mr. Ahrens served as the president of Bristol Myers Products Division and Richardson Vicks Health Care Division where he was responsible for such brands as Nyquil(TM) and Oil of Olay(TM). Mr. Stewart is a 16 year Richardson Vicks veteran where he was Director of Sales, before becoming President of the Thompson's Minwax Company, where he directed the increase of sales of the company from under $40 million to over $180 million annually.
"Marketing great products and then creating consumer pull for them is what Bill Stewart and I have built our careers on. We plan to apply those solid principles to Naturade(TM)," said Ahrens. Stewart added, "The Naturade business is a great one with a fine heritage and should be very responsive to good marketing and sales techniques." Changes implemented to date include the acceleration of new product development efforts and the appointment of a Vice President of Sales. |
